T0	Participants 69 85	post-transplant.
T1	Participants 122 410	patients achieving tacrolimus whole-blood concentrations of â‰¥10 ng/mL within 3 days of kidney transplantation, after randomization either to standard dosing (control group) or post-transplantation dosing guided by a 2-hour (C(2) ) level following a preoperative tacrolimus dose (T2 group)
T2	Participants 771 782	monitoring.
T3	Participants 783 851	Participants received concomitant mycophenolate mofetil and steroids
T4	Participants 853 964	RESULTS Ninety patients were recruited, of which 84 were included in the analysis (control group n=43; T2 group